Caption Management, LLC Intellia Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $1.32 Million - $1.84 Million	67,100 Added 268.4%	92,100 $1.89 Million
Q2 2024 Aug 14, 2024	SELL	$20.02 - $27.22 $420,420 - $571,620	-21,000 Reduced 45.65%	25,000 $559,000
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $202,470 - $278,800	8,500 Added 22.67%	46,000 $1.27 Million
Q4 2023 Feb 14, 2024	SELL	$23.16 - $32.34 $173,700 - $242,550	-7,500 Reduced 16.67%	37,500 $1.14 Million
Q3 2023 Nov 14, 2023	SELL	$31.62 - $45.78 $474,300 - $686,700	-15,000 Reduced 25.0%	45,000 $1.42 Million
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $249,749 - $336,150	-7,500 Reduced 11.11%	60,000 $2.24 Million
Q4 2022 Feb 14, 2023	SELL	$33.21 - $62.69 $1.66 Million - $3.13 Million	-50,000 Reduced 42.55%	67,500 $2.36 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $4.99 Million - $6.63 Million	92,500 Added 370.0%	117,500 $6.57 Million
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $6.5 Million - $12.9 Million	-168,900 Reduced 87.11%	25,000 $1.29 Million
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $14.3 Million - $29.2 Million	-245,100 Reduced 55.83%	193,900 $14.1 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $16.6 Million - $44.2 Million	273,000 Added 164.46%	439,000 $71.1 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $7.73 Million - $13.9 Million	166,000 New	166,000 $13.3 Million

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.